240.12
Schlusskurs vom Vortag:
$241.16
Offen:
$243.37
24-Stunden-Volumen:
1.57M
Relative Volume:
1.13
Marktkapitalisierung:
$39.47B
Einnahmen:
$3.08B
Nettoeinkommen (Verlust:
$860.33M
KGV:
46.66
EPS:
5.1463
Netto-Cashflow:
$1.35B
1W Leistung:
+9.40%
1M Leistung:
+3.50%
6M Leistung:
-15.56%
1J Leistung:
+10.50%
Veeva Systems Inc Stock (VEEV) Company Profile
Firmenname
Veeva Systems Inc
Sektor
Branche
Telefon
925-452-6500
Adresse
4280 HACIENDA DRIVE, PLEASANTON, CA
Vergleichen Sie VEEV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
VEEV
Veeva Systems Inc
|
240.12 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.27 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.79 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.15 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.53 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-07 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-09-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-05-29 | Bestätigt | Needham | Buy |
| 2025-01-23 | Herabstufung | Goldman | Buy → Sell |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-19 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-08-27 | Bestätigt | Citigroup | Buy |
| 2024-07-09 | Eingeleitet | BTIG Research | Buy |
| 2023-10-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | Eingeleitet | Jefferies | Buy |
| 2023-06-28 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-17 | Herabstufung | Truist | Buy → Hold |
| 2023-02-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-12-06 | Eingeleitet | Cowen | Market Perform |
| 2022-12-02 | Bestätigt | Needham | Buy |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | Goldman | Buy |
| 2022-06-21 | Fortgesetzt | Guggenheim | Buy |
| 2022-03-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2022-01-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Fortgesetzt | Stifel | Buy |
| 2021-09-02 | Bestätigt | BofA Securities | Buy |
| 2021-09-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2021-09-02 | Bestätigt | Needham | Buy |
| 2021-09-02 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Eingeleitet | Cowen | Outperform |
| 2021-03-31 | Hochstufung | UBS | Sell → Neutral |
| 2021-01-07 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-10-14 | Fortgesetzt | UBS | Sell |
| 2020-08-28 | Bestätigt | Needham | Buy |
| 2020-07-23 | Eingeleitet | FBN Securities | Outperform |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-06-08 | Eingeleitet | Citigroup | Buy |
| 2020-05-29 | Bestätigt | Needham | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-02-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-14 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | Bestätigt | Canaccord Genuity | Hold |
| 2019-09-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | Bestätigt | Needham | Buy |
| 2019-06-07 | Eingeleitet | Goldman | Neutral |
| 2019-05-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-27 | Bestätigt | Needham | Buy |
Alle ansehen
Veeva Systems Inc Aktie (VEEV) Neueste Nachrichten
Here's How Much You'd Have If You Invested $1000 in Veeva Systems a Decade Ago - Yahoo Finance
Peregrine Capital Management LLC Decreases Stake in Veeva Systems Inc. $VEEV - MarketBeat
Cerity Partners LLC Grows Position in Veeva Systems Inc. $VEEV - MarketBeat
Why Veeva Systems (VEEV) Is Up 8.0% After US$2 Billion Buyback And New Cloud Launch - Yahoo Finance
Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing - Sahm
How Veeva Systems Inc. Class stock behaves in tightening cycles2025 Trading Recap & Momentum Based Trading Ideas - ulpravda.ru
Market Leaders: Is Veeva Systems Inc. Class stock among top earnings plays2025 Trading Volume Trends & Low Drawdown Trading Techniques - ulpravda.ru
Is Veeva Systems Inc. Class stock among top earnings plays2025 Market Sentiment & Stock Timing and Entry Methods - ulpravda.ru
Is Veeva Systems Inc. (VEE) stock safe for risk averse investorsWeekly Trade Report & Expert Curated Trade Setup Alerts - ulpravda.ru
Can Veeva Systems Inc. stock sustain revenue growthJuly 2025 Review & Safe Capital Growth Tips - ulpravda.ru
Veeva to Present at the J.P. Morgan 2026 Healthcare Conference - MarketScreener
How Veeva Systems Inc. stock reacts to Fed rate cutsLong Setup & Daily Chart Pattern Signals - ulpravda.ru
Is Veeva Systems Inc. stock a top pick in earnings seasonBull Run & AI Enhanced Execution Alerts - ulpravda.ru
Truist Securities upgrades Veeva Systems stock rating to Buy on growth outlook - Investing.com Canada
Veeva, BioMarin Enter Long-Term Strategic Partnership - Contract Pharma
Veeva and BioMarin form strategic partnership to accelerate therapies By Investing.com - Investing.com Canada
Veeva Systems Expands Long-Term Partnership With BioMarin Pharmaceutical - Nasdaq
Veeva and BioMarin Form Long-Term Strategic Partnership - PR Newswire
Spire Wealth Management Buys 20,669 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Tran Capital Management L.P. Has $24.74 Million Holdings in Veeva Systems Inc. $VEEV - MarketBeat
Navigating the Complex World of IVD Clinical Trials: Insights from Industry Leaders - Veeva
Novo Nordisk Stock Climbs After Expanding Veeva Vault CRM Partnership - Yahoo Finance
Novo Nordisk’s International Operations Adopt Veeva Vault CRM - Contract Pharma
Veeva Expands Partnership With Novo Nordisk Through Vault CRM Adoption - Nasdaq
Life Science Software Market Competition Analysis 2025: How Players Are Shaping Growth - EIN News
How Novo Nordisk is using AI to support its global drug rollout - Stock Titan
Novo Nordisk International Operations Commits to Veeva Vault CRM - Sahm
Barclays Reaffirms Their Buy Rating on Veeva Systems (VEEV) - The Globe and Mail
Veeva Systems (VEEV) Stock Trades Up, Here Is Why - The Globe and Mail
Veeva Systems Inc. $VEEV Holdings Trimmed by Torray Investment Partners LLC - MarketBeat
Robeco Institutional Asset Management B.V. Has $238.74 Million Stock Holdings in Veeva Systems Inc. $VEEV - MarketBeat
Veeva Announces Share Repurchase Program - Sahm
Veeva Systems announces first-ever $2 billion share buyback - MSN
Veeva Systems (NYSE:VEEV) Board Authorizes Share Repurchase Program - MarketBeat
Veeva Systems (VEEV) Launches $2 Billion Share Buyback Program - GuruFocus
Veeva Systems To Buy Back Up To $2 Bln Of Shares Of Its Class A Common Stock - Nasdaq
Veeva Systems (VEEV) Initiates $2 Billion Share Buyback Program - GuruFocus
Veeva Systems announces $2 billion share buyback program By Investing.com - Investing.com Nigeria
Veeva announces share repurchase program - marketscreener.com
Veeva Systems announces $2 billion share buyback program - Investing.com
Veeva (VEEV) Initiates $2 Billion Share Buyback Program - GuruFocus
Veeva Systems Announces First-Ever $2 Billion Share Buyback - TipRanks
Veeva Systems stock rises after announcing $2 billion share buyback By Investing.com - Investing.com Canada
Veeva Systems Inc Announces $2 Billion Share Repurchase Program - TradingView — Track All Markets
Veeva Systems authorizes $2 billion share repurchase program - StreetInsider
A Look At Veeva Systems (VEEV) Valuation After Recent Weak Share Price Momentum - Yahoo Finance
Veeva Systems Inc. $VEEV Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Veeva Systems: Recent Sell-Off Derisks The Stock, But Watch Slowing Growth (Rating Upgrade) (NYSE:VEEV) - Seeking Alpha
What drives Veeva Systems Inc VEE stock priceDividend Stability Analysis & Accelerated Financial Growth - earlytimes.in
Software Has Been Battered by AI. Shopify, Veeva, and 3 More Stocks to Play a Turnaround. - Barron's
Veeva Systems (NYSE:VEEV) Stock Tracks Russell 1000 Index Composite - Kalkine Media
Finanzdaten der Veeva Systems Inc-Aktie (VEEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):